uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate: Efficacy, safety, QoL results and subgroup analysis
Univ S Florida, H Lee Moffitt Canc Ctr, Oncol, Tampa, FL USA..
Univ Kentucky, Oncol, Lexington, KY USA..
Univ Texas Hlth Sci Ctr Houston, Nucl Med, Houston, TX 77030 USA..
Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA..
Show others and affiliations
2016 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 27, no 6, 420PDArticle in journal, Meeting abstract (Refereed) Published
Place, publisher, year, edition, pages
2016. Vol. 27, no 6, 420PD
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-317512DOI: 10.1093/annonc/mdw369.5ISI: 000393912500418OAI: oai:DiVA.org:uu-317512DiVA: diva2:1088571
Conference
41st Congress of the European-Society-for-Medical-Oncology (ESMO). Copenhagen, October 07-11, 2016
Available from: 2017-04-13 Created: 2017-04-13 Last updated: 2017-04-24

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Öberg, Kjell E.
By organisation
Endocrine Tumor Biology
In the same journal
Annals of Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 29 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf